Sarah C. Moody
-
- Effects and risks of endocrine disrupting chemicals 2
-
- Sperm and Testicular Function 2
-
- Testicular diseases and treatments 3
-
- Renal and related cancers 3
- Epigenetics and DNA Methylation 2
- TGF-β signaling in diseases 2
-
- Animal testing and alternatives 2
-
- Adipose Tissue and Metabolism 2
- Co-authors
- Kate L. LovelandCatherine ItmanMark P. HedgerPatrick WesternArturo AnadónStephan NeumannNancy De BriyneNatalie A. Sims
- Journals
- Nature Communications (1 paper)Endocrinology (4 papers)American Journal of Physiology-Endocrinology and Metabolism (1 paper)
- Partner nations
- AustraliaGermanyUnited States
In The Last Decade
Sarah C. Moody
12 papers receiving 202 citations
Peers
Comparison fields: 5 of 56
- Health, Toxicology and Mutagenesis 70
- Reproductive Medicine 36
- Cancer Research 32
- Equine 3
- Pharmacology 30
Countries citing papers authored by Sarah C. Moody
This map shows the geographic impact of Sarah C. Moody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah C. Moody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah C. Moody more than expected).
Fields of papers citing papers by Sarah C. Moody
This network shows the impact of papers produced by Sarah C. Moody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah C. Moody. The network helps show where Sarah C. Moody may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah C. Moody, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 4 | |
| 3 | 2022 | 5 | |
| 4 | 2021 | 20 | |
| 5 | 2021 | 31 | |
| 6 | 2020 | 4 | |
| 7 | 2020 | 6 | |
| 8 | 2020 | 19 | |
| 9 | 2018 | 20 | |
| 10 | 2016 | 29 | |
| 11 | 2015 | 15 | |
| 12 | 2013 | 54 |
About Sarah C. Moody
Sarah C. Moody is a scholar working on Toxicology, Small Animals and Reproductive Medicine, having authored 12 papers that have together received 208 indexed citations. Recurring topics across this work include Testicular diseases and treatments (3 papers), Renal and related cancers (3 papers), Effects and risks of endocrine disrupting chemicals (2 papers), Epigenetics and DNA Methylation (2 papers), TGF-β signaling in diseases (2 papers), Sperm and Testicular Function (2 papers), Animal testing and alternatives (2 papers) and Adipose Tissue and Metabolism (2 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (70 citations), Reproductive Medicine (36 citations) and Cancer Research (32 citations). Sarah C. Moody has collaborated with scholars based in Australia, Germany and United States. Frequent co-authors include Kate L. Loveland, Catherine Itman, Mark P. Hedger, Patrick Western, Arturo Anadón, Stephan Neumann, Nancy De Briyne, Natalie A. Sims, Brian G. Drew and Rachelle W. Johnson. Their work appears in journals such as Nature Communications, Endocrinology and American Journal of Physiology-Endocrinology and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.